云南省人群乳腺癌生存率分析

职业与健康 ›› 2024, Vol. 40 ›› Issue (24): 3406-3410.

云南省人群乳腺癌生存率分析

朱云芳¹, 刘月², 杨沧江¹, 文洪梅¹, 石青萍¹, 陈杨¹

1.云南省疾病预防控制中心慢性传染性疾病防制所,云南昆明 650022;
2.昆明医科大学海源学院公共卫生系,云南昆明 650106

收稿日期:2024-04-11 修回日期:2024-04-22 出版日期:2024-12-15 发布日期:2026-04-09
通信作者: 陈杨,主任医师,E-mail：497505047@qq.com
作者简介:朱云芳,女,主管医师,主要从事慢性非传染性疾病预防与控制工作。

Analysis of breast cancer survival rate among population in Yunnan Province

ZHU Yunfang¹, LIU Yue², YANG Cangjiang¹, WEN Hongmei¹, SHI Qingping¹, CHEN Yang¹

1. Institute of Chronic Infectious Disease Prevention and Control,Yunnan Center for Disease Control and Prevention,Kunming,Yunnan 650022,China;
2. Department of Public Health,Haiyuan College,Kunming Medical University,Kunming,Yunnan 650106,China

Received:2024-04-11 Revised:2024-04-22 Online:2024-12-15 Published:2026-04-09
Contact: CHEN Yang,Chief physician,E-mail：497505047@qq.com

摘要/Abstract

摘要： 目的了解云南省乳腺癌生存现况,为恶性肿瘤防治提供参考依据。方法以云南省肿瘤登记地区1974—2022年收集的乳腺癌病例为研究对象,采用寿命表法和Kaplan-Maier法计算生存率,Cox回归进行多因素分析,并探究相关人口学和疾病状况特征对乳腺癌生存的影响。结果共纳入云南省36 058例乳腺癌患者,患者年龄[M（P₂₅,P₇₅）]为51（44,59）岁,45~<55岁年龄组患者最多为12 962例（37.50%）,≥75岁年龄组发病人数最少为1 797例（5.00%）。乳腺癌死亡7 813例（21.70%）,男性535例,女性7 448例。中位生存期为256个月。1、3、5年生存率分别为85.00%、78.00%和73.00%,女性生存率为85.00%、78.00%和74.00%,总体高于男性,分别为68.00%、60.00%和57.00%。城市1、3、5年生存率分别为85.00%、78.00%和74.00%,农村分别为85.00%、78.00%和72.00%,生存率随着年龄别的升高而降低。结论 2022年云南省乳腺癌生存率低于全国平均水平,云南省乳腺癌患者的生存情况虽有所提高,但与我国经济发达地区相比生存率仍较低。早发现早诊断早治疗是提高乳腺癌生存率的有效方法,需针对云南省的发病生存特点进一步加强乳腺癌防治工作。

关键词: 云南省, 乳腺癌, 人群, 生存率, 生存分析

Abstract: Objective To understand the survival status of breast cancer in Yunnan Province,provide a reference basis for the prevention and treatment of malignant tumors. Methods The breast cancer cases collected from 1974 to 2022 in the tumor registration area of Yunnan Province were used as the study population,the survival rates were calculated using the life table method and Kaplan-Maier method,the Cox regression was used for multifactor analysis,and the influence of relevant demographic and disease status characteristics on breast cancer survival was explored. Results A total of 36 058 patients with breast cancer in Yunnan Province were included,the age of patients[M（P₂₅,P₇₅）] was 51（44,59）years old,the age group of 45-<55 years had the highest number of patients（12 962 cases,37.50%）,and the age group of ≥75 years had the lowest number of patients（1 797 cases,5.00%）. There were 7 813（21.70%） deaths from breast cancer,535 in males and 7 448 in females. The median survival time was 256 months. 1,3 and 5 year survival rates were 85.00%,78.00% and 73.00%,respectively,with females having overall higher survival rates（85.00%,78.00% and 74.00%） than males（68.00%,60.00% and 57.00%）. 1,3 and 5 year survival rates in urban area were 85.00%,78.00% and 74.00%,respectively,while those in rural area were 85.00%,78.00% and 72.00%,respectively,and survival rate decreased with increasing age. Conclusions The survival rate of breast cancer in Yunnan Province in 2022 is lower than the national average. Although the survival of breast cancer patients in Yunnan Province has improved,the survival rate is still low compared with that in economically developed regions of China. The early detection,early diagnosis and early treatment is an effective method to improve the survival rate of breast cancer,and it is necessary to further strengthen the prevention and control of breast cancer according to the morbidity and survival characteristics of Yunnan Province.

Key words: Yunnan Province, Breast cancer, Population, Survival rate, Survival analysis

中图分类号:

R195.4

朱云芳, 刘月, 杨沧江, 文洪梅, 石青萍, 陈杨. 云南省人群乳腺癌生存率分析. [J]职业与健康, 2024, 40(24): 3406-3410.

ZHU Yunfang, LIU Yue, YANG Cangjiang, WEN Hongmei, SHI Qingping, CHEN Yang. Analysis of breast cancer survival rate among population in Yunnan Province. [J]OCCUPATION AND HEALTH, 2024, 40(24): 3406-3410.

参考文献

[1] 李庆华,周晓平,张清媛.男性乳腺癌治疗的研究进展[J].现代肿瘤医学,2021,29(8):1462-1465.
[2] 徐兵河. 晚期转移性乳腺癌治疗迎来新希望[J].抗癌之窗,2018(5):14-15.
[3] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates ofincidence and mortality worldwide for 36cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[4] 陈万青,郑荣寿.中国女性乳腺癌发病死亡和生存状况[J].中国肿瘤临床,2015,42(13):668-674.
[5] SANT M,ALLEMANI C,CAPOCACCIA R,et al.Stage at diagnosis is a key explanation of differences in breastcancer survival across Europe[J].Int J Cancer,2003,106(3):416-422.
[6] DAFNI U,TSOURTI Z,ALATSATHIANOS I.Breast cancer statistics in the European Union:Incidence and survival across European countries[J].Breast Care(Basel),2019,14(6):344-353.
[7] FAN L,STRASSER-WEIPPL K,LI J J,et al.Breast cancer in China[J].Lancet Oncol,2014,15(7):e279-e289.
[8] 陈万青,曹毛毛.加强癌症早诊早治,实施健康中国战略[J].中国肿瘤,2019,28(9):643-645.
[9] CAO M,LI H,SUN D,et al.Cancer screening in China:The current status,challenges,and suggestions[J].Cancer Lett,2021,506:120-127.
[10] 李利娟,张寰,梁晓峰,等.乳腺癌高危人群预防措施的研究进展[J].中国肿瘤临床,2020,47(1):39-42.
[11] 何明艳,朱碧琪,钟媛,等.2005—2013年中国女性乳腺癌发病及死亡趋势分析[J].中华疾病控制杂志,2019,23(1):10-14.
[12] 朱云芳,文洪梅,秦明芳,等.2011—2016年云南省肿瘤登记地区女性乳腺癌发病和死亡情况分析[J].实用肿瘤学杂志,2021,35(1):18-22.
[13] 崔芳芳,鲍俊哲,王琳琳,等.1990—2019年中国女性“两癌”疾病负担变化趋势及预测分析[J].中国卫生统计,2022,39(5):647-652.
[14] 杨建华,罗赛美,龙欣甜,等.2017年云南省肿瘤登记地区恶性肿瘤发病与死亡分析[J].实用肿瘤学杂志,2023,37(1):6-10.
[15] 邹小农,贾漫漫,王鑫,等.《2020全球癌症报告》要点解读[J].中国胸心血管外科临床杂志,2021,28(1):11-18.
[16] 仲雷,商亮,张珈瑞,等.中国乳腺癌患者预后改善的思考[J].中国医师进修杂志,2021,44(9):769-771.
[17] 师金,梁迪,李道娟,等.全球女性乳腺癌流行情况研究[J].中国肿瘤,2017,26(9):683-690.
[18] 杜建姝. 中国乳腺癌现状[J].世界最新医学信息文摘,2019,19(46):371-372.
[19] 胡玉宁,程绍强.男性乳腺癌临床特征及内分泌治疗的研究进展[J].医学综述,2020,26(14):2770-2774.
[20] ABDELWAHAB YOUSEF A J.Male breast cancer:Epidemiology and risk factors[J].Semi Oncol,2017,44(4):267-272.
[21] MHSE D,A ZAVEDO E.Male breast cancer clinical features,risk factors,and current diagnosticand therapeutic approaches[J].Int J Clin Med,2014,5(17):1068-1086.
[22] SUNG H,FERLAY J,SIEGEL R L,et al.Global CancerStatistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.
[23] DING R,XIAO Y,MO M,et al.Breast cancer screenin and early diagnosis in Chinese women[J].Cancer Biol Med,2022,19(4):450-467.
[24] 张雅聪,吕章艳,宋方方,等.全球及我国乳腺癌发病和死亡变化趋势[J].肿瘤综合治疗电子杂志,2021,7(2):14-20.
[25] 包鹤龄,王临虹,王丽敏,等.中国2013年35~69岁女性人群子宫颈癌和乳腺癌筛查率及影响因素研究[J].中华流行病学杂志,2018, 39(2):208-212.
[26] BRITT K L,CUZICK J,PHILLIPS K A.Key steps for effective breast cancer prevention[J].Nat RevCancer,2020,20(8):417-436.
[27] 李贺,左婷婷,曾红梅,等.不同年龄女性乳腺癌患者的临床特征及预后分析[J].中华肿瘤杂志,2021,43(1):126-131.
[28] GAUDET M M,CARTER B D,BRINTON L A,et al.Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14cohort studies[J].Int J Epidemiol,2017,46(3):881-893.
[29] DALL G V,BRITT K L.Estrogen Effects on the Mammary Gland in Early and Late Lifeand Breast Cancer Risk[J].Front Oncol,2017,7:110.
[30] DING R,XIAO Y,MO M,et al.Breast cancer screening andearly diagnosisin Chinese women[J].Cancer Biol Med,2022,19(4):450-467.